The Effects of Trimetazidine on P-Wave Duration and Dispersion in Heart Failure Patients

---

Atıf İçin Kopyala

GUNES Y., Tuncer M., GUNTEKIN U., Akdag S., GÜMRÜKÇÜOĞLU H. A.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, cilt.32, sa.2, ss.239-244, 2009 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 32 Sayı: 2
• Basım Tarihi: 2009
• Doi Numarası: 10.1111/j.1540-8159.2008.02208.x
• Dergi Adı: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.239-244
• Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

Background: P-wave duration and dispersion (PWD) have been shown to be noninvasive predictors for development of atrial fibrillation. Thus, it may be possible to attenuate atrial fibrillation risk through normalization of P-wave duration and dispersion. Trimetazidine, a metabolic modulator, has been reported to improve cardiac function in heart failure (HF) patients.